Contrast‐enhancing tumor growth dynamics of preoperative, treatment‐naive human glioblastoma von Ellingson, Benjamin M., Nguyen, Huytram N., Lai, Albert, Nechifor, Ruben E., Zaw, Okkar, Pope, Whitney B., Yong, William H., Nghiemphu, Phioanh L., Liau, Linda M., Cloughesy, Timothy F.

Volltext

Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI von Ellingson, Benjamin M, Lai, Albert, Nguyen, Huytram N, Nghiemphu, Phioanh L, Pope, Whitney B, Cloughesy, Timothy F

Volltext

Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide von Robins, H Ian, Nguyen, HuyTram N, Field, Aaron, Howard, Steven, Salamat, Shahriar, Deming, Dustin A

Volltext

Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy von Nguyen, HuyTram N, Lie, Amy, Li, Tie, Chowdhury, Reshmi, Liu, Fei, Ozer, Byram, Wei, Bowen, Green, Richard M, Ellingson, Benjamin M, Wang, He-Jing, Elashoff, Robert, Liau, Linda M, Yong, William H, Nghiemphu, Phioanh L, Cloughesy, Timothy, Lai, Albert

Volltext

Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Eff... von Kong, Xiao-Tang, Nguyen, Nhung T., Choi, Yoon J., Zhang, Guicheng, Nguyen, HuyTram N., Filka, Emese, Green, Stacey, Yong, William H., Liau, Linda M., Green, Richard M., Kaprealian, Tania, Pope, Whitney B., Nghiemphu, P. Leia, Cloughesy, Timothy, Lassman, Andrew, Lai, Albert

Volltext

The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide von Rapkins, Robert W, Wang, Fan, Nguyen, HuyTram N, Cloughesy, Timothy F, Lai, Albert, Ha, Wendy, Nowak, Anna K, Hitchins, Megan P, McDonald, Kerrie L

Volltext

D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-Induced MIR148A Promoter Methylation von Li, Tie, Cox, Christopher D, Ozer, Byram H, Nguyen, Nhung T, Nguyen, HuyTram N, Lai, Thomas J, Li, Sichen, Liu, Fei, Kornblum, Harley I, Liau, Linda M, Nghiemphu, Phioanh L, Cloughesy, Timothy F, Lai, Albert

Volltext

Vision loss in glioblastoma: Disease mimicking presumed therapeutic toxicity von Nguyen, HuyTram N, Vo, Kevin B H, Howard, Steven, Salamat, M Shahriar, Rowely, Howard, Robins, H Ian

Volltext

Phase II Study of Bortezomib in Combination with Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients with Newly-Diagnosed Glioblastoma Multiforme: Safety... von Kong, Xiao-Tang, Nguyen, Nhung T., Choi, Yoon J., Zhang, Guicheng, Nguyen, HuyTram N., Filka, Emese, Green, Stacey, Yong, William H., Liau, Linda M., Green, Richard M., Kaprealian, Tania, Pope, Whitney B., Nghiemphu, P. Leia, Cloughesy, Tim, Lassman, Andrew, Lai, Albert

Volltext

Benefit of MGMT methylation in glioblastoma in relation to hTERT promoter mutation von Nguyen, HuyTram N, Li, Tie, Lie, Amy, Ozer, Byram H, Chowdhury, Reshmi, Liu, Fei, Wei, Bowen, Wang, He-jing, Elashoff, Robert M., Liau, Linda M., Yong, William H., Ellingson, Benjamin M., Nghiemphu, Phioanh Leia, Cloughesy, Timothy Francis, Lai, Albert

Volltext

Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide von Robins, H Ian, Nguyen, HuyTram N, Field, Aaron, Howard, Steven, Salamat, Shahriar, Deming, Dustin A

Volltext